Showing 1,321 - 1,340 results of 21,342 for search '(( significant effects decrease ) OR ( significant decrease decrease ))', query time: 0.48s Refine Results
  1. 1321
  2. 1322
  3. 1323
  4. 1324
  5. 1325
  6. 1326
  7. 1327
  8. 1328
  9. 1329
  10. 1330
  11. 1331
  12. 1332

    Supplementary file 1_Bupropion decreases plasma levels of asymmetric dimethylarginine and ameliorates renal injury by modulation of Ddah1, Oatp4c1, Oct2, and Mate1 in rats with ade... by Lulu Huang (469776)

    Published 2025
    “…In adenine-induced chronic renal injury rats, long-term administration of BUP significantly decreased the serum concentration of ADMA and creatinine by 12.78% and 38.85%, respectively, ameliorated interstitial lesions and fibrosis and upregulated Ddah1, Oatp4c1, Oct2, Mate1. …”
  13. 1333
  14. 1334
  15. 1335
  16. 1336
  17. 1337
  18. 1338
  19. 1339

    Risk of bias summary. by Duc Tran Quang (20564967)

    Published 2025
    “…The study encompassed 36 selected studies involving 44 effect sizes and 914 participants. The effectiveness of the TRE was found to vary across health conditions, with modest weight loss observed in healthy individuals (pooled effect size -1.04 Kg, 95% CI: -1.42 to -0.65) and more significant weight reduction seen in participants with chronic diseases (pooled effect size -3.33 Kg, 95% CI: -5.05 to -1.62) and overweight/obesity (pooled effect size -4.21 Kg, 95% CI: -5.23 to -3.10). …”
  20. 1340

    Criteria for study selection. by Duc Tran Quang (20564967)

    Published 2025
    “…The study encompassed 36 selected studies involving 44 effect sizes and 914 participants. The effectiveness of the TRE was found to vary across health conditions, with modest weight loss observed in healthy individuals (pooled effect size -1.04 Kg, 95% CI: -1.42 to -0.65) and more significant weight reduction seen in participants with chronic diseases (pooled effect size -3.33 Kg, 95% CI: -5.05 to -1.62) and overweight/obesity (pooled effect size -4.21 Kg, 95% CI: -5.23 to -3.10). …”